abstract |
The present disclosure generally relates to Toll-like receptor modulator compounds, such as diamino pyrido[3,2 D] pyrimidine compounds and pharmaceutical compositions, and pharmaceutical compositions, particularly those that modulate Toll-like receptors (eg, TLR-8) It relates to methods of manufacture and use. |